首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2126553

轉導增強劑試劑市場：依產品類型、載體類型、應用、最終用戶和地區分類

Transduction Enhancer Reagents Market, By Product Type, By Vector Type, By Application, By End User, By Geography

出版日期: 2026年08月24日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，轉導增強劑試劑市場價值將達到 1.195 億美元，到 2033 年將達到 2.105 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1.195億美元
歷史數據涵蓋的時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.40%	2033年市場規模預測：	2.105億美元

轉導增強劑是一類特殊的生化化合物，它透過增強病毒顆粒與細胞膜的相互作用，提高病毒載體介導的基因向目標細胞轉移的效率，且不會損害細胞活力。它們被廣泛應用於基因治療、細胞治療和分子生物學研究中，以最大限度地提高病毒轉導效率。

全球轉導增強劑試劑市場的發展主要受基因治療和細胞治療產品線擴張、生產基礎設施投資增加以及慢病毒和腺結合病毒（AAV）載體應用日益廣泛等因素驅動。主要終端使用者包括製藥公司、生技公司、合約研發生產力機構（CDMO）、合約研究機構（CRO）和學術機構。同時，聚異亮氨酸酯（polyblen）、硫酸魚精蛋白和專有的新一代增強劑等產品正被廣泛應用於各種研究和治療領域。

市場動態

全球轉導增強劑試劑市場正受到基因和細胞療法研發快速進展、慢病毒和腺相關病毒（AAV）載體應用日益廣泛以及基因組學、基因工程和再生醫學領域投資不斷成長的推動。細胞和基因療法生產能力的提升以及專業合約研發生產機構（CDMO）的擴張預計將進一步促進轉導增強劑試劑市場的成長。

然而，轉導增強劑樣本市場的成長受到許多因素的限制，例如專有配方高成本、監管嚴格、生物安全要求苛刻，以及某些傳統增強劑的細胞毒性問題。儘管如此，開發用於原代培養細胞和幹細胞的無毒、無血清且符合GMP標準的增強劑仍有巨大的發展空間。亞太地區，特別是中國、韓國和印度的基因治療生產擴張，也為全球轉導增強劑試劑市場帶來了潛在的成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球轉導增強劑試劑市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球轉導增強劑試劑市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球轉導增強劑試劑市場中使用的各種策略矩陣，相關人員將能夠做出更順利的決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza Group Ltd.
- Takara Bio Inc.
- Sartorius AG
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- Bio-Techne Corporation
- GenScript Biotech Corporation
- OZ Biosciences SAS

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9981

Transduction Enhancer Reagents Market is estimated to be valued at USD 119.5 Mn in 2026 and is expected to reach USD 210.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 119.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.40%	2033 Value Projection:	USD 210.5 Mn

Transduction enhancer reagents are specialized biochemical compounds that improve the efficacy of viral vector-mediated gene delivery to target cells by enhancing the interaction between the viral particle and the cell membrane, without compromising the viability of the cell. They are routinely used in gene therapy, cell therapy and molecular biology research applications to maximize viral transduction.

The global transduction enhancer reagents market is driven by the increasing pipeline of gene and cell therapies, growing investments in manufacturing infrastructure, and increasing use of lentiviral and adeno-associated viral (AAV) vectors. Major end users include pharmaceutical and biotechnology companies, CDMOs, CROs, and academic institutions, whereas products such as polybrene, protamine sulfate, and proprietary next-generation enhancers serve a variety of research and therapeutic applications.

Market Dynamics

The global transduction enhancer reagents market is driven by rapid growth in the development of gene and cell therapy, increasing utilization of lentiviral and AAV vectors, increasing investment in genomics, gene modification, and regenerative medicine. Increasing capacity of cell and gene therapy manufacturing, and expansion of specialized CDMOs are expected to drive the transduction enhancer reagents market.

However, the growth of transduction enhancer reagents market is limited by factors such as high cost of proprietary formulations, strict regulatory and biosafety regulations, and cytotoxicity concerns associated with some conventional enhancers. Nevertheless, there is significant scope for development of non-toxic serum-free and GMP-compatible enhancers for primary and stem cells. Growth in gene therapy manufacturing in Asia-Pacific region, especially in China, South Korea, and India, is also a potential growth opportunity in the global transduction enhancer reagents market.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global transduction enhancer reagents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Takara Bio Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Promega Corporation, Bio-Techne Corporation, GenScript Biotech Corporation, and OZ Biosciences SAS
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global transduction enhancer reagents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transduction enhancer reagents market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
Polymer-based
Peptide-based
Lipid-based
Others
Vector Type Insights (Revenue, USD Mn, 2021 - 2033)
Lentiviral
Retroviral
AAV
Others
Application Insights (Revenue, USD Mn, 2021 - 2033)
Gene and Cell Therapies
Drug Development and Research
Vaccine Development
Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
Pharma and Biotech Firms
Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs)
Academic and Research Institutes
Contract Research Organizations (CROs)
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Thermo Fisher Scientific Inc.
Merck KGaA
Lonza Group Ltd.
Takara Bio Inc.
Sartorius AG
Bio-Rad Laboratories, Inc.
Promega Corporation
Bio-Techne Corporation
GenScript Biotech Corporation
OZ Biosciences SAS

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Transduction Enhancer Reagents Market, By Product Type
- Global Transduction Enhancer Reagents Market, By Vector Type
- Global Transduction Enhancer Reagents Market, By Application
- Global Transduction Enhancer Reagents Market, By End User
- Global Transduction Enhancer Reagents Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Transduction Enhancer Reagents Market, By Product Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Polymer-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Peptide-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lipid-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Transduction Enhancer Reagents Market, By Vector Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Lentiviral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retroviral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
AAV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Transduction Enhancer Reagents Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Gene and Cell Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Drug Development and Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Transduction Enhancer Reagents Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharma and Biotech Firms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Transduction Enhancer Reagents Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Company Profile
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Lonza Group Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Takara Bio Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sartorius AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Promega Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bio-Techne Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GenScript Biotech Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- OZ Biosciences SAS
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies